Global Hirudin Market Data Survey Report 2025
![](/report_cover/10278/global-hirudin-market-data-survey-report-2025-heyreport_en.gif)
Summary
Hirudin is a naturally occurring peptide in the salivary glands of medicinal leeches (such as Hirudo medicinalis) that has a blood anticoagulant property. Hirudin is the most potent natural inhibitor of thrombin.
The global Hirudin market will reach Volume Million USD in 2017 with CAGR xx% 2018-2025. The main contents of the report including:
Global market size and forecast
Regional market size, production data and export & import
Key manufacturers (manufacturing sites, capacity and production, product specifications etc.)
Average market price by SUK
Major applications
Key manufacturers are included based on manufacturing sites, capacity and production, product specifications etc.:
Major applications as follows:
Hirudin is a naturally occurring peptide in the salivary glands of medicinal leeches (such as Hirudo medicinalis) that has a blood anticoagulant property. Hirudin is the most potent natural inhibitor of thrombin.
The global Hirudin market will reach Volume Million USD in 2017 with CAGR xx% 2018-2025. The main contents of the report including:
Global market size and forecast
Regional market size, production data and export & import
Key manufacturers (manufacturing sites, capacity and production, product specifications etc.)
Average market price by SUK
Major applications
Key manufacturers are included based on manufacturing sites, capacity and production, product specifications etc.:
- The Medicines Company
- Keyken
- Minapharm
- Abbott
- SALUBRIS
- Pfizer, Inc
- Teva Pharmaceutical Industries Ltd
- DUOPUTAI
- Pentapharm
Major applications as follows:
- Thrombosis Disease
- Tumor Disease
- Others
- Asia-Pacific
- North America
- Europe
- South America
- Middle East & Africa
1 GLOBAL MARKET OVERVIEW
1.1 Scope of Statistics
1.1.1 Scope of Products
1.1.2 Scope of Manufacturers
1.1.3 Scope of Application
1.1.4 Scope of Regions/Countries
1.2 Global Market Size
2 REGIONAL MARKET
2.1 Regional Production
2.2 Regional Demand
2.3 Regional Trade
3 KEY MANUFACTURERS
3.1 The Medicines Company
3.1.2 Company Information
3.1.2 Product Specifications
3.1.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
3.2 Keyken
3.2.1 Company Information
3.2.2 Product Specifications
3.2.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
3.3 Minapharm
3.3.1 Company Information
3.3.2 Product Specifications
3.3.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
3.4 Abbott
3.4.1 Company Information
3.4.2 Product Specifications
3.4.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
3.5 SALUBRIS
3.5.1 Company Information
3.5.2 Product Specifications
3.5.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
3.6 Pfizer, Inc
3.6.1 Company Information
3.6.2 Product Specifications
3.6.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
3.7 Teva Pharmaceutical Industries Ltd
3.7.1 Company Information
3.7.2 Product Specifications
3.7.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
3.8 DUOPUTAI
3.8.1 Company Information
3.8.2 Product Specifications
3.8.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
3.9 Pentapharm
3.9.1 Company Information
3.9.2 Product Specifications
3.9.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
4 MAJOR APPLICATION
4.1 Thrombosis Disease
4.1.1 Overview
4.1.2 Thrombosis Disease Market Size and Forecast
4.2 Tumor Disease
4.2.1 Overview
4.2.2 Tumor Disease Market Size and Forecast
4.3 Others
4.3.1 Overview
4.3.2 Others Market Size and Forecast
5 MARKET PRICE
5.1 Overview
5.2 Price by SUK
6 CONCLUSION
1.1 Scope of Statistics
1.1.1 Scope of Products
1.1.2 Scope of Manufacturers
1.1.3 Scope of Application
1.1.4 Scope of Regions/Countries
1.2 Global Market Size
2 REGIONAL MARKET
2.1 Regional Production
2.2 Regional Demand
2.3 Regional Trade
3 KEY MANUFACTURERS
3.1 The Medicines Company
3.1.2 Company Information
3.1.2 Product Specifications
3.1.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
3.2 Keyken
3.2.1 Company Information
3.2.2 Product Specifications
3.2.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
3.3 Minapharm
3.3.1 Company Information
3.3.2 Product Specifications
3.3.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
3.4 Abbott
3.4.1 Company Information
3.4.2 Product Specifications
3.4.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
3.5 SALUBRIS
3.5.1 Company Information
3.5.2 Product Specifications
3.5.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
3.6 Pfizer, Inc
3.6.1 Company Information
3.6.2 Product Specifications
3.6.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
3.7 Teva Pharmaceutical Industries Ltd
3.7.1 Company Information
3.7.2 Product Specifications
3.7.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
3.8 DUOPUTAI
3.8.1 Company Information
3.8.2 Product Specifications
3.8.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
3.9 Pentapharm
3.9.1 Company Information
3.9.2 Product Specifications
3.9.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
4 MAJOR APPLICATION
4.1 Thrombosis Disease
4.1.1 Overview
4.1.2 Thrombosis Disease Market Size and Forecast
4.2 Tumor Disease
4.2.1 Overview
4.2.2 Tumor Disease Market Size and Forecast
4.3 Others
4.3.1 Overview
4.3.2 Others Market Size and Forecast
5 MARKET PRICE
5.1 Overview
5.2 Price by SUK
6 CONCLUSION
LIST OF TABLES
Tab REGIONAL PRODUCTION 2011-2017 (VALUE)
Tab Regional Production 2011-2017 (Volume)
Tab Regional Demand and CAGR 2011-2017 (Value)
Tab Regional Demand and CAGR 2011-2017 (Volume)
Tab Regional Demand Forecast and CAGR 2018-2025 (Value)
Tab Regional Demand Forecast and CAGR 2018-2025 (Volume)
Tab Regional Export 2011-2017 (Value)
Tab Regional Export 2011-2017 (Volume)
Tab Regional Import 2011-2017 (Value)
Tab Regional Import 2011-2017 (Volume)
Tab Sales Revenue, Volume, Price, Cost and Margin of The Medicines Company
Tab Sales Revenue, Volume, Price, Cost and Margin of Keyken
Tab Sales Revenue, Volume, Price, Cost and Margin of Minapharm
Tab Sales Revenue, Volume, Price, Cost and Margin of Abbott
Tab Sales Revenue, Volume, Price, Cost and Margin of SALUBRIS
Tab Sales Revenue, Volume, Price, Cost and Margin of Pfizer, Inc
Tab Sales Revenue, Volume, Price, Cost and Margin of Teva Pharmaceutical Industries Ltd
Tab Sales Revenue, Volume, Price, Cost and Margin of DUOPUTAI
Tab Sales Revenue, Volume, Price, Cost and Margin of Pentapharm
Tab Market Price by Region
Tab Market Price by Manufacturers
Tab Market Price by Application
Tab Price by SUK (Popular Goods on the Market)
Tab REGIONAL PRODUCTION 2011-2017 (VALUE)
Tab Regional Production 2011-2017 (Volume)
Tab Regional Demand and CAGR 2011-2017 (Value)
Tab Regional Demand and CAGR 2011-2017 (Volume)
Tab Regional Demand Forecast and CAGR 2018-2025 (Value)
Tab Regional Demand Forecast and CAGR 2018-2025 (Volume)
Tab Regional Export 2011-2017 (Value)
Tab Regional Export 2011-2017 (Volume)
Tab Regional Import 2011-2017 (Value)
Tab Regional Import 2011-2017 (Volume)
Tab Sales Revenue, Volume, Price, Cost and Margin of The Medicines Company
Tab Sales Revenue, Volume, Price, Cost and Margin of Keyken
Tab Sales Revenue, Volume, Price, Cost and Margin of Minapharm
Tab Sales Revenue, Volume, Price, Cost and Margin of Abbott
Tab Sales Revenue, Volume, Price, Cost and Margin of SALUBRIS
Tab Sales Revenue, Volume, Price, Cost and Margin of Pfizer, Inc
Tab Sales Revenue, Volume, Price, Cost and Margin of Teva Pharmaceutical Industries Ltd
Tab Sales Revenue, Volume, Price, Cost and Margin of DUOPUTAI
Tab Sales Revenue, Volume, Price, Cost and Margin of Pentapharm
Tab Market Price by Region
Tab Market Price by Manufacturers
Tab Market Price by Application
Tab Price by SUK (Popular Goods on the Market)
LIST OF FIGURES
Fig Global Hirudin Market Size and CAGR 2011-2017 (Value)
Fig Global Hirudin Market Size and CAGR 2011-2017 (Volume)
Fig Global Hirudin Market Forecast and CAGR 2018-2025 (Value)
Fig Global Hirudin Market Forecast and CAGR 2018-2025 (Volume)
Fig Thrombosis Disease Market Size and CAGR 2011-2017 (Value)
Fig Thrombosis Disease Market Size and CAGR 2011-2017 (Volume)
Fig Thrombosis Disease Market Forecast and CAGR 2018-2025 (Value)
Fig Thrombosis Disease Market Forecast and CAGR 2018-2025 (Volume)
Fig Tumor Disease Market Size and CAGR 2011-2017 (Value)
Fig Tumor Disease Market Size and CAGR 2011-2017 (Volume)
Fig Tumor Disease Market Forecast and CAGR 2018-2025 (Value)
Fig Tumor Disease Market Forecast and CAGR 2018-2025 (Volume)
Fig Others Market Size and CAGR 2011-2017 (Value)
Fig Others Market Size and CAGR 2011-2017 (Volume)
Fig Others Market Forecast and CAGR 2018-2025 (Value)
Fig Others Market Forecast and CAGR 2018-2025 (Volume)
Fig Global Market Price 2011-2017
Fig Global Market Price 2018-2025
Fig Global Hirudin Market Size and CAGR 2011-2017 (Value)
Fig Global Hirudin Market Size and CAGR 2011-2017 (Volume)
Fig Global Hirudin Market Forecast and CAGR 2018-2025 (Value)
Fig Global Hirudin Market Forecast and CAGR 2018-2025 (Volume)
Fig Thrombosis Disease Market Size and CAGR 2011-2017 (Value)
Fig Thrombosis Disease Market Size and CAGR 2011-2017 (Volume)
Fig Thrombosis Disease Market Forecast and CAGR 2018-2025 (Value)
Fig Thrombosis Disease Market Forecast and CAGR 2018-2025 (Volume)
Fig Tumor Disease Market Size and CAGR 2011-2017 (Value)
Fig Tumor Disease Market Size and CAGR 2011-2017 (Volume)
Fig Tumor Disease Market Forecast and CAGR 2018-2025 (Value)
Fig Tumor Disease Market Forecast and CAGR 2018-2025 (Volume)
Fig Others Market Size and CAGR 2011-2017 (Value)
Fig Others Market Size and CAGR 2011-2017 (Volume)
Fig Others Market Forecast and CAGR 2018-2025 (Value)
Fig Others Market Forecast and CAGR 2018-2025 (Volume)
Fig Global Market Price 2011-2017
Fig Global Market Price 2018-2025